Nectar Lifesciences share news, announcements and annual reports
NSE: NECLIFEBSE: 532649Pharmaceuticals & BiotechnologySmall Cap
Nectar Lifesciences Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jul 2005
Last close ₹10.20down ₹0.13 (1.26%)BSE ₹10.29
Share price at the NSE close on 30 Oct 2026. Previous close ₹10.33.
30 Oct: open ₹10.43, high ₹10.43, low ₹9.82
52-week range of traded prices to 30 Oct 2026
₹9.30Low, 30 Mar 2026₹22.40High, 23 Dec 2025
- Under NSE's long-term additional surveillance, stage I, on the list for 30 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹198 Cr2,221st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.34
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −31.9%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹171 crore of one-off items, the largest of them in the quarter to Sep 2025.
- −9.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −15.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 95,05079.2% delivered
Nectar Lifesciences share news and announcements
590 announcements, routine notices left out, newest first. Page 12 of 12.
Sep 2008
29 Sep · Dividend
Members in their Annual General Meeting held on September 29, 2008 have declared the final dividend of Rs.4/- per equity share (40 % on the face value of Rs. 10/- per equity share) for the financial year 2007-08. The dividend will be paid latest by October 28, 2008.29 Sep · Meeting
Outcome of Annual General Meeting of the Company held on September 29, 2008. Further the Company has informed the Exchange that the members at the Annual General Meeting of the Company held on September 29, 2008 have approved the Resolution for the stock split i.e. sub division of every equity share of Rs. 10/- each into 10 equity shares of Re. 1/- each. The details of the outcome of the AGM shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.16 Sep · Meeting
Members of the Company in their Extraordinary General Meeting held on September 16, 2008, have approved the following resolutions: 1. Authorizing the Board to issue further 2,949,436 equity shares on preferential basis under section 81(1A) of the Companies Act, 1956. 2. Authorizing the Board to issue GDRs/ADRs/ or any other international offering up to 50 Million US Dollars. Further, the Company has submitted a copy of the proceedings of the meeting. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.8 Sep · Meeting
Notice of the Annual General Meeting of the Shareholders of the company to be held on September 29, 2008. The copy of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements) For more details click here.
Aug 2008
29 Aug · Split/Others
Board of Directors in their meeting held on August 28, 2008 have approved the followings: 1. The issue of warrants, that are convertible into equity shares, on preferential basis upto the amount of US$ 2.5 Million to: i. CVCIGP - II Employee Rosehill Limited. ii. CVCIGP - II Client Rosehill Limited. 2. The stock split i.e. sub-division of every equity shares of face value of Rs. 10/- each into 10 equity shares of face value of Re. 1/- each and consequential changes in Memorandum & Articles of Associations of the company. To resolutions towards seeking approval of shareholders for the above purposes, would be proposed in the forthcoming Annual General Meeting scheduled to be held on September 29, 2008.26 Aug · Meeting
Notice of Extraordinary General Meeting scheduled to be held on September 16, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.25 Aug · Issue of ADRs/GDRs/Others
Board of Directors in their meeting held on August 22, 2008 has approved the followings: 1) The signing of non binding term sheets for issue of preferential equity with: a) Citi Venture Capital International, b) Everest Capital (M) Limited. 2) The issue of GDRs/ ADRs/ or any other international offering up to 50 Million US Dollars. To seek approval of shareholders for the above purposes u/s 81(1A) of the Companies Act, 1956, an Extra - Ordinary General Meeting of the company is proposed to be convened on September 16, 2008.21 Aug · Board meeting
To consider, inter-alia, the issue of GDR's / ADR's / equity shares or warrants / securities convertible into equity shares / any other domestic / international offering and to decide the matters incidental or ancillary thereto.
Jul 2008
18 Jul · Board meeting
To consider, inter alia amongst other items, the Unaudited Financial (Provisional) Results of the company for the quarter ended on June 30, 2008.
Jun 2008
20 Jun · Management
The Board of Directors in their Meeting held on June 20, 2008 have appointed Mr. Saurabh Goyal on the Board as an Executive Director for a period of five years w.e.f June 20, 2008, subject to the approval of shareholders in their General Meeting. Further Mrs Raman Goyal has resigned from directorship of the company w.e.f June 20, 2008 and consequently also ceased to Wholetime Director of the company. The Board, while taking note of the resignation, placed on record its sincere gratitude for the services rendered by Mrs Raman Goyal as Director as well as Wholetime Director.20 Jun · Updates
Statement as required under clause 20(b) of the Listing Agreement. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.20 Jun · Meeting
Board of Directors in their meeting held on June 20, 2008 have inter-alia decided and approved:- (1) To convene the Annual General Meeting of the Members of the Company on September 29, 2008. (2) To close the Register of Members and Share Transfer Books from September 20, 2008 to September 29, 2008 (Both days inclusive) for the purpose of Annual General Meeting and Dividend, if any, declared by the Members in their Annual General Meeting.20 Jun · Dividend
Board of Directors of the Company at its meeting held on June 20, 2008 has decided and approved the recommendation of 40% Final Dividend i.e. Rs.4/- per equity share to the Members of the Company, out of profits of the Company for the financial year 2007-08.11 Jun · Board meeting
To consider and approve inter-alia amongst other items:(1) The Audited Financial Results for Financial Year 2007-08, Balance Sheet of the company as at 31.03.2008 and Profit & Loss Accounts for the financial year ended on 31.03.2008 and matters related thereto.(2) The date of Annual General Meeting of Members of the Company for the Financial Year 2007-08 and matters related thereto.(3) Recommendation of final dividend to the Members of the company for Financial Year 2007-08 and fix the Book closure dates and matters related thereto.
Apr 2008
29 Apr · Board meeting postponed
Nectar Lifesciences Limited had informed the Exchange regarding the notice of Board Meeting to be held on April 30, 2008 to consider inter alia amongst other items, the Unaudited Financial (Provisional) Results of the company for the quarter ended on March 31, 2008. The Company has now informed the Exchange that it has been decided by the company to submit and publish the Audited Financial Results for the financial year ended March 31, 2008 on or before June 30, 2008, that is, within a period of 3 months from the end of the last quarter of the financial year 2007-08. Therefore, the unaudited Financial (Provisional) Results of the company for the quarter ended on March 31, 2008 will not be placed before Board meeting scheduled to be held on April 30, 2008, which, accordingly, stands postponed."21 Apr · Board meeting
To consider, inter alia amongst other items, the Unaudited Financial (Provisional) Results of the company for the quarter ended on March 31, 2008.
Jan 2008
17 Jan · Board meeting
To consider, inter alia amongst other items, the Unaudited Financial (Provisional) Results of the company for the quarter ended on December 31, 2007.7 Jan · Allotment of Equity Shares
The Allotment committee of Board of Directors of the company at their Meeting held on 07.01.2008, have allotted 339,430 equity shares of Rs.10/- each of the company upon conversion of Zero Coupon Convertible Bonds Due 2011 (FCCBs) of US$ 2,000,000/-. The conversion has been took place at a predetermined price of Rs.263.22 at a predetermined exchange rate of US$ 1 = Rs.44.6725. After the allotment of these shares, the paid up equity capital of the company stands increased to Rs.152,260,970/- comprising of 15,226,097 equity shares of Rs.10/- each
Oct 2007
18 Oct · Board meeting
To consider and approve, inter alia amongst other items, the Unaudited Financial (Provisional) Results of the company for the quarter ended on September 30, 2007.10 Oct · Miscellaneous
Adjustment of Conversion Price of FCCBs issued by the Company. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.5 Oct · Amendments to the Articles of Association
In the Annual General Meeting held on September 28, 2007, the Members have resolved to amend the articles no. 179 of Articles of Associations of the company regarding the execution of documents under the common seal (other than shares/debenture certificate) in presence of any director or secretary.5 Oct · Meeting
Minutes of the Annual General Meeting of the Members of the Company held on September 28, 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Sep 2007
28 Sep · Meeting
"The Members in their Annual General Meeting held on today i.e. 28th September, 2007 have declared the final dividend of Rs.2/- per equity share (20% on the face value of Rs.10/- per equity share) for the financial year 2006-07. The dividend will be paid latest by 27th October, 2007". Further, the company has submitted to the Exchange a copy of the Outcome of the Annual General Meeting of the members of the Company held on September 28, 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.17 Sep · Miscellaneous
Statement as required under clause 20(b) of the Listing Agreement for the year ended March 31, 2007. A copy of the Statement shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.11 Sep · Miscellaneous
The Board of Directors in their meeting held on today i.e. 3rd September, 2007 have decided to wind up the operations of Company' wholly owned subsidiary M/s Chempharma Private Limited, Sri Lanka, as operation through the subsidiary are no more profitable for the company due to changed circumstances10 Sep · Management
The Board of Directors in their meeting held on today i.e. 3rd September, 2007 have appointed Smt. Raman Goyal as a Wholetime Director of the company for a period of Five Years w.e.f. 01.09.2007, subject to the approval of members in their forthcoming Annual General Meeting3 Sep · Meeting
Board of Directors in their meeting held on September 03, 2007 have inter-alia decided and approved: (1) To convene the Annual General Meeting of the Members of the Company on September 28, 2007. (2) The recommendation of 20% Final Dividend i.e. Rs. 2/- per equity share to the Members of the Company, out of profits of the Company for the financial year 2006-07. (3) To close the Register of Members and Share Transfer Books from 20th September 2007 to 28th September 2007 (Both days inclusive) for the purpose of Annual General Meeting and Dividend, if any, declared by the members in their Annual General Meeting.
Aug 2007
27 Aug · Board meeting
To consider and approve inter-alia amongst other items: (1) The Balance Sheet of the Company as at March 31, 2007 and Profit & Loss Accounts for the Financial year ended on March 31, 2007 and matters related thereto. (2) The Date of Annual General Meeting of Members of the Company for the Financial year 2006-07 and matters related thereto. (3) Recommendation of Final Dividend to the Members of the Company for Financial year 2006-07 and fix the book Closure dates and matters related thereto.2 Aug · Management
The Board of Directors in their Meeting held on today i.e. 30.07.2007 have appointed Mrs. Raman Goyal on the Board as an additional director of the company who shall hold the office upto the date of next Annual General Meeting. She belongs to the promoters group of the company
Jul 2007
18 Jul · Board meeting
Meeting on 30 Jul 2007: “Unaudited financial results for quarter ended June 30, 2007”
Jun 2007
12 Jun · Management
Board of Directors vide resolution dated May 31, 2007 have reappointed Sh. Sanjiv Goyal as a Chairman & Managing Director of the company for a period of Five Years w.e.f. 01.06.2007, subject to the approval of members in their General Meeting. Further the Company is sending to its members the abstract of terms of re-appointment of Sh. Sanjiv Goyal, as per the provisions of Section 302 of the Companies Act, 1956. Further the Company has submitted a copy of the abstract. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
May 2007
7 May · Management
The Board of Directors in their Meeting held on today i.e. 28.04.2007 have appointed Mr. Basant Kumar Goswami I.A.S. (retd.) on the Board as an additional director (Independent director) of the company who shall hold the office upto the date of next Annual General Meeting7 May · Miscellaneous
A fire has occurred in early morning on today i.e. 07.05.2007, at Bulk Drug Plant of the company at Unit I, Village Saidpura, Tehsil Derabassi, Distt. Mohali (Punjab). The financial losses could not be worked out as detailed investigations are required for this purpose. However, the plant has been fully insured to meet losses caused by fire. The Company is taking necessary steps to restore the normalcy of production
Apr 2007
30 Apr · Miscellaneous
Nector Lifesciences Limited, a major player in the sterile cephalosporins and sterile bulk, has injected Rs.75 crores to set up two manufacturing facilities at Baddi in Himachal Pradesh viz. Cephalosporin Formulation Unit and Empty Hard Gelatin Capsule Unit. The Baddi projects have been funded by initial Public Offering (IPO) and Foreign Currency Convertible Bonds (FCCB). Part of the FCCB, Rs.25 crores, is also being utilised to fund the 8MW power generation unit at Derabassi in Punjab, which is agro-based using rice husk etc. and expected to go on stream in May 2007. The company recently also ventured into menthol and its allied products under the natural products segment. It has facilities at Jammu and Derebassi and 90% of its production is exported28 Apr · Dividend
The Audit Committee in its Meeting held on 27.04.2007 has recommended to the Board of Directors a Final Dividend @ 20% to the Members, which the Board has accepted to consider at the time of adoption of audited financial statements for the year ended 31.03.200721 Apr · Board meeting
Meeting on 28 Apr 2007: “Unaudited Financial Results for the Qtr ended March 31, 2007”2 Apr · Management
Mrs. Raman Goyal has resigned from the Directorship of the Company and hence also ceased to be a whole time director of the Company.
Mar 2007
13 Mar · E-mail ID for Investor Complaints
Company has already designated the e-mail ID of the Company Secretary and Compliance Officer i.e sunderlal@neclife.com, for the purpose of registration of complaints by investors and correspondence with them for redressel of their grievances.
Feb 2007
12 Feb · Management
Mr. V.D. Aggarwal has resigned from the Directorship of the Company
Jan 2007
15 Jan · Board meeting
To consider, inter alia amongst other items, the Unaudited Financial (Provisional) Results of the company for the quarter ended on December 31,2006.